Found: 32
Select item for more details and to access through your institution.
Impact of new direct‐acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection.
- Published in:
- Liver International, 2024, v. 44, n. 6, p. 1383, doi. 10.1111/liv.15875
- By:
- Publication type:
- Article
CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis.
- Published in:
- Medical Decision Making, 2024, v. 44, n. 3, p. 296, doi. 10.1177/0272989X241234070
- By:
- Publication type:
- Article
An Exploratory Analysis of the Cost-Effectiveness of a Multi-cancer Early Detection Blood Test Compared with Standard of Care Screening in Ontario, Canada.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 4, p. 393, doi. 10.1007/s40273-023-01345-9
- By:
- Publication type:
- Article
Hepatitis C Attributable Healthcare Costs and Mortality among Immigrants: A Population-Based Matched Cohort Study.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2024, v. 2024, p. 1, doi. 10.1155/2024/5573068
- By:
- Publication type:
- Article
The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysis.
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0290646
- By:
- Publication type:
- Article
A province-by-province cost-effectiveness analysis and budget impact analysis of one-time birth cohort screening of hepatitis C virus (HCV) infection in Canada.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39521-8
- By:
- Publication type:
- Article
The impact of expanded access to direct acting antivirals for Hepatitis C virus on patient outcomes in Canada.
- Published in:
- PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0284914
- By:
- Publication type:
- Article
A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC).
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 8, p. 945, doi. 10.1007/s40273-023-01279-2
- By:
- Publication type:
- Article
Impact of direct‐acting antiviral treatment on health utility in patients with chronic hepatitis C in hospital and community settings.
- Published in:
- Liver International, 2023, v. 43, n. 4, p. 805, doi. 10.1111/liv.15518
- By:
- Publication type:
- Article
Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 4, p. 413, doi. 10.1007/s40273-022-01236-5
- By:
- Publication type:
- Article
Cost‐utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada.
- Published in:
- Haemophilia, 2023, v. 29, n. 2, p. 488, doi. 10.1111/hae.14723
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of hepatitis C virus (HCV) point‐of‐care assay for HCV screening.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 787, doi. 10.1111/liv.15123
- By:
- Publication type:
- Article
Estimation of COVID-19 Period Prevalence and the Undiagnosed Population in Canadian Provinces: Model-Based Analysis.
- Published in:
- JMIR Public Health & Surveillance, 2021, v. 7, n. 9, p. 1, doi. 10.2196/26409
- By:
- Publication type:
- Article
Subsistence Life and Aging Agony: A Case of Cultural Affluence in Hong Kong.
- Published in:
- Social Development Issues (Social Development Issues), 2021, v. 43, n. 2, p. 16
- By:
- Publication type:
- Article
Economic evaluation of pharmacists prescribing for minor ailments in Ontario, Canada: a cost-minimization analysis.
- Published in:
- International Journal of Pharmacy Practice, 2021, v. 29, n. 3, p. 228, doi. 10.1093/ijpp/riab006
- By:
- Publication type:
- Article
Understanding the Feasibility of Implementing CAR T-Cell Therapies from a Canadian Perspective.
- Published in:
- Healthcare Policy, 2021, v. 16, n. 3, p. 89, doi. 10.12927/hcpol.2021.26430
- By:
- Publication type:
- Article
Social Policy on the Cusp: Values, Institutions and Change.
- Published in:
- 2021
- By:
- Publication type:
- Book Review
Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population‐based cohort studies.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 12, p. 1419, doi. 10.1111/jvh.13373
- By:
- Publication type:
- Article
The emergency department as a setting‐specific opportunity for population‐based hepatitis C screening: An economic evaluation.
- Published in:
- Liver International, 2020, v. 40, n. 6, p. 1282, doi. 10.1111/liv.14458
- By:
- Publication type:
- Article
Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cost-Effectiveness of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B in Canada.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach.
- Published in:
- Liver International, 2020, v. 40, n. 1, p. 51, doi. 10.1111/liv.14247
- By:
- Publication type:
- Article
A model-based framework for chronic hepatitis C prevalence estimation.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0225366
- By:
- Publication type:
- Article
Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials.
- Published in:
- Systematic Reviews, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s13643-019-1126-1
- By:
- Publication type:
- Article
Cost‐Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- Oncologist, 2018, v. 23, n. 2, p. 225, doi. 10.1634/theoncologist.2017-0277
- By:
- Publication type:
- Article
Population-based estimate of hepatitis C virus prevalence in Ontario, Canada.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0191184
- By:
- Publication type:
- Article
Canadian hepatitis C virus screening guideline: a disconnect between evidence and recommendations.
- Published in:
- 2017
- By:
- Publication type:
- letter
Cost-effectiveness of screening for hepatitis C in Canada.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2015, v. 187, n. 3, p. 182, doi. 10.1503/cmaj.140711
- By:
- Publication type:
- Article
Screening for HCV.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
How much are we spending? The estimation of research expenditures on cardiovascular disease in Canada.
- Published in:
- BMC Health Services Research, 2012, v. 12, n. 1, p. 281, doi. 10.1186/1472-6963-12-281
- By:
- Publication type:
- Article
Cost effectiveness of screening immigrants for hepatitis B.
- Published in:
- Liver International, 2011, v. 31, n. 8, p. 1179, doi. 10.1111/j.1478-3231.2011.02559.x
- By:
- Publication type:
- Article
BOOK REVIEW:: "New Theories of Welfare", Tony Fitzpatrick.
- Published in:
- 2007
- By:
- Publication type:
- Book Review